Active substance · J07CA12
Diphtheria tetanus pertussis hepatitis b poliomyelitis vaccine
Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ07
- Pharmacological subgroupJ07C
- Chemical subgroupJ07CABacterial and viral vaccines, combined
- Chemical substanceJ07CA12
Where it is registered
Each register with its number of medicines and a few of them.
European Union
EMA · 1 medicine · Historical list
All medicines with Diphtheria tetanus pertussis hepatitis b poliomyelitis vaccine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
7 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Infanrix Penta | European Union | Cancelled | GlaxoSmithKline Biologicals S.A. | ||
| Vaxelis | European Union | Authorised | MCM Vaccine B.V. | ||
| Hexyon | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Hexacima | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Infanrix Hexa | European Union | Authorised | GlaxoSmithKline Biologicals S.A. | ||
| Infanrix Hexa VaccineCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) | ||
| Hexavac | European Union | Withdrawn | Sanofi Pasteur MSD, SNC |